Clinical Trial Update: Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing voriconazole to itraconazole for primary prophylaxis of invasive fungal infections in allogeneic hematopoietic stem cell transplant reci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• Itraconazole (Sporanox) (Itraconazole)
• Voriconazole (Vfend) (voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Antifungal Prophylaxis of Invasive Fungal Infections | Phase 3 | Status: COMPLETED | Results posted: 2010-03-10